A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML
| Autor: | Jonas, Brian A., Potter, Laura A., Galkin, Maria, Tuscano, Joseph M. |
|---|---|
| Zdroj: | In Leukemia Research Reports 2023 19 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|